Fresenius Ag [Dem 50 (FSNUF) 50.5500 $FSNUF
Global Dialysis Products and Services (Hemodialysis Products, Peritoneal Dialysis Products
M2 - Thu Sep 11, 5:50AM CDT
Research and Markets (http://www.researchandmarkets.com/research/c8vw2r/dialysis_products) has announced the addition of the "Dialysis Products and Services Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2014 - 2020" report to their offering. According to the National Institutes of Health, the worldwide number of patients with chronic kidney disease is rising rapidly and is expected to rise by approximately 5% to 8% annually. Increasing prevalence of diabetes and hypertension are the two primary causes of end stage renal disease in major developing countries like China, Brazil and India and is also contributing to the growth of overall dialysis products and services market. According to the American Kidney Fund, diabetes and hypertension are responsible for 38.4% and 25% of all cases of kidney failures, respectively. Similarly, increasing geriatric population and low preference by patients above 65 years of age to opt for kidney transplant is also driving the growth of dialysis products and services market. According to the Australian Institute of Health and Welfare, the proportion of people opting for kidney transplantation decreases with age. Moreover, increasing awareness about peritoneal dialysis is expected to boost the growth of the market in the near future. The global dialysis products and services market is segmented by type of procedures and type of services. The procedures market is further segmented into hemodialysis and peritoneal dialysis. Further, the hemodialysis segment (HD) is classified into HD machine, dialyzer, access products/catheters, bloodlines, concentrates and others, which include water treatment systems and fistula needles. Hemodialysis, being the oldest and most preferred technique for dialysis procedure, Hemodialysis machines captures the largest share, of the total market in 2013. The segment is expected to lead the market during the forecast period from 2014 to 2020. Similarly, peritoneal dialysis (PD) segment is classified into concentrates/dialysate, PD machines, catheters, and transfer sets. Among these, the PD concentrates/dialysate segment is accounted for largest market share in 2013 and is expected to grow at an attractive higher growth rate during the forecast period from 2014 to 2020. The major factors responsible for the significant growth of this segment are increase in the number of patients preferring peritoneal dialysis, and rising demand of patients to be dialyzed overnight with the aid of peritoneal dialysis. Dialysis Products and Services Market, by Product type: Hemodialysis - HD Machines - Dialyzers - HD Access Products/Catheters - Bloodlines - HD Concentrates/Dialysate - Others (Water Treatment System, Fistula Needles) Peritoneal Dialysis - Concentrates/Dialysate - PD Machines - PD Catheters - PD Transfer Sets Dialysis Products and Services Market, by Type of Services: - In-center Dialysis - Home Dialysis Companies Mentioned - Asahi Kasei Corporation - B. Braun Melsungen AG - Baxter International, Inc. - C. R. Bard, Inc. - Cantel Medical Corporation - Covidien plc - DaVita Healthcare Partners, Inc. - Fresenius SE & Co. KGaA - Kawasumi Laboratories, Inc. - Medical Components, Inc. - Nikkiso Co., Ltd. - Nipro Corporation - NxStage Medical, Inc. - Rockwell Medical Technologies, Inc. For more information visit http://www.researchandmarkets.com/research/c8...s_products
DuPont appoints Ulf M. "Mark" Schneider to board
M2 - Mon Aug 04, 5:01AM CDT
Science and engineering company DuPont (NYSE
D) reported on Friday the addition of Ulf M. (Mark) Schneider to its board of directors, effective Oct. 22.
Mark Schneider Elected to DuPont Board of Directors
PR Newswire - Fri Aug 01, 3:01PM CDT
DuPont today announced the election of Ulf M. "Mark" Schneider, President and CEO of Fresenius SE & Co. KGaA to its board of directors, effective Oct. 22.
Concise Analysis of the International Enteral Feeding Devices Market
M2 - Fri Mar 07, 5:54AM CST
Research and Markets (http://www.researchandmarkets.com/research/ldl6z9/enteral_feeding) has announced the addition of the "Concise Analysis of the International Enteral Feeding Devices Market" report to their offering. This report analyzes the worldwide markets for Enteral Feeding Devices in US$ Million by the following Product Categories: Enteral Feeding Pumps, Nasogastric Tubes, and Others. The report provides separate comprehensive analytics for the US Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World. Annual estimates and forecasts are provided for the period 2010 through 2018. Also, a six-year historic analysis is provided for these markets. The report profiles 38 companies including many key and niche players such as: - American HomePatient, Inc. - Amsino International, Inc. - Applied Medical Technology, Inc. - Boston Scientific Corporation - C. R. Bard, Inc. - Caesarea Medical Electronics Ltd. - Cook Medical, Inc. - CONMED Corporation - CORPAK MedSystems, Inc. - Covidien Plc - Fresenius SE & Co. KGaA - Fresenius KABI AG - Kimberly-Clark Corporation - Moog Inc. - Nestl? HealthCare Nutrition - Nutricia Advanced Medical Nutrition - VYGON SA Market data and analytics are derived from primary and secondary research. Company profiles are primarily based on public domain information including company URLs. Please note: Reports are sold as single-site single-user licenses. Electronic versions require 24-48 hours as each copy is customized to the client with digital controls and custom watermarks. For information on site licence pricing please click on Enquire before buying. Key Topics Covered: I. Introduction, Methodology & Product Definitions II. Executive Summary 1. Industry Overview 2. Market Drivers, Trends & Issues 3. Product Overview 4. Recent Product Innovations/ Launches 5. Recent Industry Activity 6. Focus On Select Global Players 7. Global Market Perspective III. Market 1. The United States 2. Canada 3. Japan 4. Europe 5. Asia-Pacific 6. Latin America 7. Rest Of World IV. Competitive Landscape Total Companies Profiled: 38 (including Divisions/Subsidiaries - 52) - The United States (24) - Canada (1) - Europe (20) - France (3) - Germany (5) - The United Kingdom (6) - Rest of Europe (6) - Asia-Pacific (Excluding Japan) (6) - Middle East (1) For more information visit http://www.researchandmarkets.com/research/ld...al_feeding
Global Burns Clinical Trials Report - H2 2013 Edition
M2 - Fri Jan 10, 8:35AM CST
Research and Markets (http://www.researchandmarkets.com/research/4vpq56/burns_global) has announced the addition of the "Burns Global Clinical Trials Review, H2, 2013" report to their offering. This report provides elemental information and data relating to the clinical trials on Burns. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Burns. Scope - Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations - Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type - Listings of discontinued trials (suspended, withdrawn and terminated) Top Companies Participating in Burns Therapeutics Clinical Trials - MediWound Ltd. - Fibrocell Science, Inc. - Bayer AG - Plethora Solutions Holdings plc - Kuros Biosurgery AG - Klinikum St. Georg gGmbH - HealOr Ltd. - Fresenius SE & Co. KGaA - Birken AG - Baxter International Inc. Clinical Trial Overview of Top Institutes / Government - The University of Texas Medical Branch at Galveston - Massachusetts General Hospital - Shriners Hospitals for Children - U.S. Army Institute of Surgical Research - Shiraz University of Medical Sciences - National Institute of General Medical Sciences - Tehran University of Medical Sciences - Association of Dutch Burn Centres - Third Military Medical University - Johns Hopkins University For more information visit http://www.researchandmarkets.com/research/4v...rns_global
Malnutrition Global Clinical Trials Review, H2 2013: Profiles Players Such as Danone Research B.V., Royal Numico N.V. and Helen Keller International
M2 - Fri Jan 10, 5:15AM CST
Research and Markets (http://www.researchandmarkets.com/research/38jm2d/malnutrition) has announced the addition of the "Malnutrition Global Clinical Trials Review, H2, 2013" report to their offering. The clinical trial report, Malnutrition Global Clinical Trials Review, H2, 2013" provides data on the Malnutrition clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Malnutrition. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Malnutrition. Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease. Scope - Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations - Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type - Listings of discontinued trials (suspended, withdrawn and terminated) Companies Mentioned: -Abbott Laboratories -Aga Khan University -Baxter International Inc. -Baylor College of Medicine -Copenhagen University Hospital at Herlev -Cornell University -Danone Research B.V. -DaVita HealthCare Partners Inc. -Deutsche Gesellschaft fur Internationale Zusammenarbeit GmbH -Epicentre Biotechnologies -Fresenius SE & Co. KGaA -Helen Keller International -Royal Numico N.V. -University Hospital Inselspital, Berne -University of California, Davis -University of Oxford -University of Tampere -Washington University School of Medicine For more information visit http://www.researchandmarkets.com/research/38...lnutrition About Research and Markets Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Intravenous Solutions (Parenteral Nutrition) - 2013 Global Strategic Business Report Features Giants such as Actavis, Inc and Hospira, Inc.
M2 - Mon Sep 02, 12:17PM CDT
Research and Markets (http://www.researchandmarkets.com/research/jvnnn3/intravenous#summary) has announced the addition of the "Intravenous Solutions (Parenteral Nutrition) - Global Strategic Business Report" report to their offering. This report analyzes the worldwide markets for Intravenous Solutions (Parenteral Nutrition) in US$ Million. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World. Annual estimates and forecasts are provided for the period 2010 through 2018. Also, a six-year historic analysis is provided for these markets. The report profiles 30 companies including many key and niche players such as: - Actavis Inc. - B. Braun Melsungen AG - Baxter International Inc. - Claris Lifesciences Ltd. - Fresenius SE & Co. KGaA - Fresenius Kabi AG - Sino-Swed Pharmaceutical Corp. Ltd. - Hospira Inc. - Otsuka Pharmaceutical Factory Inc. - Marck Biosciences Ltd. - Sichuan Kelun Pharmaceutical Co. Ltd. - Terumo Corporation - The Galenica Group - Vifor Pharma. Market data and analytics are derived from primary and secondary research. Company profiles are primarily based on public domain information including company URLs. Key Topics Covered: Normal 0 false false false MicrosoftInternetExplorer4 I. Introduction, Methodology & Product Definitions Ii. Executive Summary 1. Industry Overview 2. Intravenous Solutions 3. Parenteral Nutrition - An Overview 4. Product Launches 5. Recent Industry Activity 6. Focus On Select Global Players 7. Global Market Perspective Iii. Market Iv. Competitive Landscape For more information visit http://www.researchandmarkets.com/research/jv...us#summary About Research and Markets Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Global Dialysis Products and Services (Hemodialysis Products, Peritoneal Dialysis Products
M2 - Thu Sep 11, 5:50AM CDT
Research and Markets (http://www.researchandmarkets.com/research/c8vw2r/dialysis_products) has announced the addition of the "Dialysis Products and Services Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2014 - 2020" report to their offering. According to the National Institutes of Health, the worldwide number of patients with chronic kidney disease is rising rapidly and is expected to rise by approximately 5% to 8% annually. Increasing prevalence of diabetes and hypertension are the two primary causes of end stage renal disease in major developing countries like China, Brazil and India and is also contributing to the growth of overall dialysis products and services market. According to the American Kidney Fund, diabetes and hypertension are responsible for 38.4% and 25% of all cases of kidney failures, respectively. Similarly, increasing geriatric population and low preference by patients above 65 years of age to opt for kidney transplant is also driving the growth of dialysis products and services market. According to the Australian Institute of Health and Welfare, the proportion of people opting for kidney transplantation decreases with age. Moreover, increasing awareness about peritoneal dialysis is expected to boost the growth of the market in the near future. The global dialysis products and services market is segmented by type of procedures and type of services. The procedures market is further segmented into hemodialysis and peritoneal dialysis. Further, the hemodialysis segment (HD) is classified into HD machine, dialyzer, access products/catheters, bloodlines, concentrates and others, which include water treatment systems and fistula needles. Hemodialysis, being the oldest and most preferred technique for dialysis procedure, Hemodialysis machines captures the largest share, of the total market in 2013. The segment is expected to lead the market during the forecast period from 2014 to 2020. Similarly, peritoneal dialysis (PD) segment is classified into concentrates/dialysate, PD machines, catheters, and transfer sets. Among these, the PD concentrates/dialysate segment is accounted for largest market share in 2013 and is expected to grow at an attractive higher growth rate during the forecast period from 2014 to 2020. The major factors responsible for the significant growth of this segment are increase in the number of patients preferring peritoneal dialysis, and rising demand of patients to be dialyzed overnight with the aid of peritoneal dialysis. Dialysis Products and Services Market, by Product type: Hemodialysis - HD Machines - Dialyzers - HD Access Products/Catheters - Bloodlines - HD Concentrates/Dialysate - Others (Water Treatment System, Fistula Needles) Peritoneal Dialysis - Concentrates/Dialysate - PD Machines - PD Catheters - PD Transfer Sets Dialysis Products and Services Market, by Type of Services: - In-center Dialysis - Home Dialysis Companies Mentioned - Asahi Kasei Corporation - B. Braun Melsungen AG - Baxter International, Inc. - C. R. Bard, Inc. - Cantel Medical Corporation - Covidien plc - DaVita Healthcare Partners, Inc. - Fresenius SE & Co. KGaA - Kawasumi Laboratories, Inc. - Medical Components, Inc. - Nikkiso Co., Ltd. - Nipro Corporation - NxStage Medical, Inc. - Rockwell Medical Technologies, Inc. For more information visit http://www.researchandmarkets.com/research/c8...s_products
DuPont appoints Ulf M. "Mark" Schneider to board
M2 - Mon Aug 04, 5:01AM CDT
Science and engineering company DuPont (NYSE
D) reported on Friday the addition of Ulf M. (Mark) Schneider to its board of directors, effective Oct. 22. Mark Schneider Elected to DuPont Board of Directors
PR Newswire - Fri Aug 01, 3:01PM CDT
DuPont today announced the election of Ulf M. "Mark" Schneider, President and CEO of Fresenius SE & Co. KGaA to its board of directors, effective Oct. 22.
Concise Analysis of the International Enteral Feeding Devices Market
M2 - Fri Mar 07, 5:54AM CST
Research and Markets (http://www.researchandmarkets.com/research/ldl6z9/enteral_feeding) has announced the addition of the "Concise Analysis of the International Enteral Feeding Devices Market" report to their offering. This report analyzes the worldwide markets for Enteral Feeding Devices in US$ Million by the following Product Categories: Enteral Feeding Pumps, Nasogastric Tubes, and Others. The report provides separate comprehensive analytics for the US Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World. Annual estimates and forecasts are provided for the period 2010 through 2018. Also, a six-year historic analysis is provided for these markets. The report profiles 38 companies including many key and niche players such as: - American HomePatient, Inc. - Amsino International, Inc. - Applied Medical Technology, Inc. - Boston Scientific Corporation - C. R. Bard, Inc. - Caesarea Medical Electronics Ltd. - Cook Medical, Inc. - CONMED Corporation - CORPAK MedSystems, Inc. - Covidien Plc - Fresenius SE & Co. KGaA - Fresenius KABI AG - Kimberly-Clark Corporation - Moog Inc. - Nestl? HealthCare Nutrition - Nutricia Advanced Medical Nutrition - VYGON SA Market data and analytics are derived from primary and secondary research. Company profiles are primarily based on public domain information including company URLs. Please note: Reports are sold as single-site single-user licenses. Electronic versions require 24-48 hours as each copy is customized to the client with digital controls and custom watermarks. For information on site licence pricing please click on Enquire before buying. Key Topics Covered: I. Introduction, Methodology & Product Definitions II. Executive Summary 1. Industry Overview 2. Market Drivers, Trends & Issues 3. Product Overview 4. Recent Product Innovations/ Launches 5. Recent Industry Activity 6. Focus On Select Global Players 7. Global Market Perspective III. Market 1. The United States 2. Canada 3. Japan 4. Europe 5. Asia-Pacific 6. Latin America 7. Rest Of World IV. Competitive Landscape Total Companies Profiled: 38 (including Divisions/Subsidiaries - 52) - The United States (24) - Canada (1) - Europe (20) - France (3) - Germany (5) - The United Kingdom (6) - Rest of Europe (6) - Asia-Pacific (Excluding Japan) (6) - Middle East (1) For more information visit http://www.researchandmarkets.com/research/ld...al_feeding
Global Burns Clinical Trials Report - H2 2013 Edition
M2 - Fri Jan 10, 8:35AM CST
Research and Markets (http://www.researchandmarkets.com/research/4vpq56/burns_global) has announced the addition of the "Burns Global Clinical Trials Review, H2, 2013" report to their offering. This report provides elemental information and data relating to the clinical trials on Burns. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Burns. Scope - Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations - Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type - Listings of discontinued trials (suspended, withdrawn and terminated) Top Companies Participating in Burns Therapeutics Clinical Trials - MediWound Ltd. - Fibrocell Science, Inc. - Bayer AG - Plethora Solutions Holdings plc - Kuros Biosurgery AG - Klinikum St. Georg gGmbH - HealOr Ltd. - Fresenius SE & Co. KGaA - Birken AG - Baxter International Inc. Clinical Trial Overview of Top Institutes / Government - The University of Texas Medical Branch at Galveston - Massachusetts General Hospital - Shriners Hospitals for Children - U.S. Army Institute of Surgical Research - Shiraz University of Medical Sciences - National Institute of General Medical Sciences - Tehran University of Medical Sciences - Association of Dutch Burn Centres - Third Military Medical University - Johns Hopkins University For more information visit http://www.researchandmarkets.com/research/4v...rns_global
Malnutrition Global Clinical Trials Review, H2 2013: Profiles Players Such as Danone Research B.V., Royal Numico N.V. and Helen Keller International
M2 - Fri Jan 10, 5:15AM CST
Research and Markets (http://www.researchandmarkets.com/research/38jm2d/malnutrition) has announced the addition of the "Malnutrition Global Clinical Trials Review, H2, 2013" report to their offering. The clinical trial report, Malnutrition Global Clinical Trials Review, H2, 2013" provides data on the Malnutrition clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Malnutrition. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Malnutrition. Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease. Scope - Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations - Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type - Listings of discontinued trials (suspended, withdrawn and terminated) Companies Mentioned: -Abbott Laboratories -Aga Khan University -Baxter International Inc. -Baylor College of Medicine -Copenhagen University Hospital at Herlev -Cornell University -Danone Research B.V. -DaVita HealthCare Partners Inc. -Deutsche Gesellschaft fur Internationale Zusammenarbeit GmbH -Epicentre Biotechnologies -Fresenius SE & Co. KGaA -Helen Keller International -Royal Numico N.V. -University Hospital Inselspital, Berne -University of California, Davis -University of Oxford -University of Tampere -Washington University School of Medicine For more information visit http://www.researchandmarkets.com/research/38...lnutrition About Research and Markets Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Intravenous Solutions (Parenteral Nutrition) - 2013 Global Strategic Business Report Features Giants such as Actavis, Inc and Hospira, Inc.
M2 - Mon Sep 02, 12:17PM CDT
Research and Markets (http://www.researchandmarkets.com/research/jvnnn3/intravenous#summary) has announced the addition of the "Intravenous Solutions (Parenteral Nutrition) - Global Strategic Business Report" report to their offering. This report analyzes the worldwide markets for Intravenous Solutions (Parenteral Nutrition) in US$ Million. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World. Annual estimates and forecasts are provided for the period 2010 through 2018. Also, a six-year historic analysis is provided for these markets. The report profiles 30 companies including many key and niche players such as: - Actavis Inc. - B. Braun Melsungen AG - Baxter International Inc. - Claris Lifesciences Ltd. - Fresenius SE & Co. KGaA - Fresenius Kabi AG - Sino-Swed Pharmaceutical Corp. Ltd. - Hospira Inc. - Otsuka Pharmaceutical Factory Inc. - Marck Biosciences Ltd. - Sichuan Kelun Pharmaceutical Co. Ltd. - Terumo Corporation - The Galenica Group - Vifor Pharma. Market data and analytics are derived from primary and secondary research. Company profiles are primarily based on public domain information including company URLs. Key Topics Covered: Normal 0 false false false MicrosoftInternetExplorer4 I. Introduction, Methodology & Product Definitions Ii. Executive Summary 1. Industry Overview 2. Intravenous Solutions 3. Parenteral Nutrition - An Overview 4. Product Launches 5. Recent Industry Activity 6. Focus On Select Global Players 7. Global Market Perspective Iii. Market Iv. Competitive Landscape For more information visit http://www.researchandmarkets.com/research/jv...us#summary About Research and Markets Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
